| http://www.w3.org/ns/prov#value | - This presentation contains certain statements that may be forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including statements relating to the product portfolio and pipeline and clinical programs of the combined company, the market opportunities for MuGard???, the sales of, market opportunities for and planned studies of ProLindac???, the market opportu
|
